Open AccessThe role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
Author(s) -
А. О. Конради,
Л. Г. Ратова,
И. В. Емельянов,
А. О. Недошивин
Publication year - 2018
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2018-11-96-99
Subject(s) - medicine , disease , beta (programming language) , pathogenesis , cardiology , intensive care medicine , computer science , programming language
Arterial hypertension (AH) is the most common noninfectious disease in the world and in Russia, associated with high cardiovascular morbidity and mortality. In August 2018, new guidelines for the diagnosis and treatment of patients with arterial hypertension were presented at the European Congress of Cardiology. The article discusses the role of the sympathetic nervous system in the pathogenesis of hypertension and the current importance of betablockers in the treatment of hypertension.